340 related articles for article (PubMed ID: 24556007)
21. Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease.
Martinez-Fernandez R; Pelissier P; Quesada JL; Klinger H; Lhommée E; Schmitt E; Fraix V; Chabardes S; Mertens P; Castrioto A; Kistner A; Broussolle E; Pollak P; Thobois S; Krack P
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):311-8. PubMed ID: 25934016
[TBL] [Abstract][Full Text] [Related]
22. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
[TBL] [Abstract][Full Text] [Related]
24. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
Daniels C; Krack P; Volkmann J; Raethjen J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
Mov Disord; 2011 Dec; 26(14):2516-21. PubMed ID: 22170276
[TBL] [Abstract][Full Text] [Related]
25. [Prevalence of mood disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation].
Maes H; Vingerhoets F; Berney A
Rev Med Suisse; 2011 Feb; 7(282):385-8. PubMed ID: 21416865
[TBL] [Abstract][Full Text] [Related]
26. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
[TBL] [Abstract][Full Text] [Related]
27. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.
Zibetti M; Merola A; Rizzi L; Ricchi V; Angrisano S; Azzaro C; Artusi CA; Arduino N; Marchisio A; Lanotte M; Rizzone M; Lopiano L
Mov Disord; 2011 Nov; 26(13):2327-34. PubMed ID: 22012750
[TBL] [Abstract][Full Text] [Related]
28. [Emotion and basal ganglia (II): what can we learn from subthalamic nucleus deep brain stimulation in Parkinson's disease?].
Péron J; Dondaine T
Rev Neurol (Paris); 2012; 168(8-9):642-8. PubMed ID: 22901366
[TBL] [Abstract][Full Text] [Related]
29. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease.
Witjas T; Kaphan E; Régis J; Jouve E; Chérif AA; Péragut JC; Azulay JP
Mov Disord; 2007 Sep; 22(12):1729-34. PubMed ID: 17557355
[TBL] [Abstract][Full Text] [Related]
30. Effect of subthalamic stimulation on mood state in Parkinson's disease: evaluation of previous facts and problems.
Takeshita S; Kurisu K; Trop L; Arita K; Akimitsu T; Verhoeff NP
Neurosurg Rev; 2005 Jul; 28(3):179-86; discussion 187. PubMed ID: 15827764
[TBL] [Abstract][Full Text] [Related]
31. Deep brain stimulation of the subthalamic nucleus in the 6-hydroxydopamine rat model of Parkinson's disease: effects on sensorimotor gating.
Lindemann C; Krauss JK; Schwabe K
Behav Brain Res; 2012 Apr; 230(1):243-50. PubMed ID: 22330948
[TBL] [Abstract][Full Text] [Related]
32. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
[TBL] [Abstract][Full Text] [Related]
33. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
34. Long-term effects of bilateral deep brain stimulation of the subthalamic nucleus on depression in patients with Parkinson's disease.
Wang X; Chang C; Geng N; Li N; Wang J; Ma J; Xue W; Zhao W; Wu H; Wang P; Gao G
Parkinsonism Relat Disord; 2009 Sep; 15(8):587-91. PubMed ID: 19403325
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of the subthalamic nucleus in Parkinson's disease: cognitive and affective changes are not linked to the motor outcome.
Perriol MP; Krystkowiak P; Defebvre L; Blond S; Destée A; Dujardin K
Parkinsonism Relat Disord; 2006 May; 12(4):205-10. PubMed ID: 16549386
[TBL] [Abstract][Full Text] [Related]
36. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
[TBL] [Abstract][Full Text] [Related]
37. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
[TBL] [Abstract][Full Text] [Related]
38. [Significant improvement of motor symptoms by deep brain stimulation of bilateral subthalamic nucleus in patients with moderate or advanced Parkinson's disease].
Chen J; Liu JL; Chen X; Qian H; Xian WB; Zhou HY; Liu YM; Ye XF; Zheng YF; Zhang SL; Chen L; Li JR; Liu ZL; Pei Z
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):291-5. PubMed ID: 21419000
[TBL] [Abstract][Full Text] [Related]
39. The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease.
Nazzaro JM; Pahwa R; Lyons KE
Parkinsonism Relat Disord; 2011 Sep; 17(8):606-9. PubMed ID: 21669545
[TBL] [Abstract][Full Text] [Related]
40. Non-motor outcomes depend on location of neurostimulation in Parkinson's disease.
Petry-Schmelzer JN; Krause M; Dembek TA; Horn A; Evans J; Ashkan K; Rizos A; Silverdale M; Schumacher W; Sack C; Loehrer PA; Fink GR; Fonoff ET; Martinez-Martin P; Antonini A; Barbe MT; Visser-Vandewalle V; Ray-Chaudhuri K; Timmermann L; Dafsari HS;
Brain; 2019 Nov; 142(11):3592-3604. PubMed ID: 31553039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
